US Edition
News from finance-magazin.de
If you want to know if Finance-magazin.de is credible or reliable, look no further. We rank Finance-magazin.de as Unknown factuality. Find out more about our methodology here.
Information about Finance-magazin.de
Where is Finance-magazin.de located?Finance-magazin.de's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Finance-magazin.de News
Europe · GermanyBioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy candidates. Analysts say the M&A deal is a way to essentially settle out of court the ongoing mRNA patent dispute between the companies following some recent CureVac legal wins. The post BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute appeared first on MedCity News.See the Story
BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
47% Center coverage: 28 sources
Credit Suisse · HamburgAround a year after Ringer left Credit Suisse, the ex-investment banker moved to a Hamburg private equity house where a special strategy was put into place. Credit Suisse Germany's long-standing investment banking head is launching a new chapter in his career: Joachim Ringer joins the Hamburg private equity investor Vorsprung Management as a partner, as the PE house announced. The ex-banker is expected to be responsible for investments in Europe…Read Article
